About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
MYGN - Myriad Genetics| Previous Close | $12.86 | Open | $12.98 |
| Volume | 434.7K | Market Cap | 1.785B |
| Yield | Last Dividend |
| Genetic Testing Market to reach $ 4.86 b... | 10/08/20 |
| Technavio has been monitoring the genetic testing market and it is poised to grow by $ 4.86 bn during 2020-2024, progressing at a CAGR of over 12% dur... | |
| Liquid Biopsy Market (COVID - 19 Updates... | 10/08/20 |
| This Liquid Biopsy Market research report is a detailed synopsis on the study of industry and its impact on the market environment. By systematically ... | |
| Liquid Biopsy Market 2020 with Impact of... | 10/06/20 |
| When globalization is growing day by day, many businesses call for global market research consisting of actionable market insights that helps with dec... | |
| COVID-19 UPDATE: Clinical Oncology Next ... | 10/05/20 |
| Data Bridge Market Research has recently added a concise research on the Clinical Oncology Next Generation Sequencing Market to depict valuable insigh... | |
| Global Clinical Oncology Next Generation... | 10/01/20 |
| Data Bridge Market Research has recently added a concise research on the Clinical Oncology Next Generation Sequencing Market to depict valuable insigh... | |
| Direct-to-consumer Genetic Testing Marke... | 09/30/20 |
| Los Angeles, United State, ??? ??? QY Research recently added a research report, Global Direct-to-consumer Genetic Testing Market Research Report 2020... | |
| Myriad Genetics Announces Inducement Awa... | 08/14/20 |
| SALT LAKE CITY, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, ???Myriad??? or the ???Company???), a global leader in molecula... | |
| Global Genomics Market Outlook 2020-2025... | 08/13/20 |
| DUBLIN--(BUSINESS WIRE)--The "Genomics Market - Growth, Trends, and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering.... | |
| Myriad Genetics Expands Board of Directo... | 07/22/20 |
| Daniel M. Skovronsky, M.D., Ph.D. Elected to Myriad???s Board of Directors. Walter (Wally) Gilbert, Ph.D., announces upcoming retirement from the Boar... | |
| Inmedix welcomes Bernie Tobin, former Pr... | 07/15/20 |
| Seasoned biotech leadership expected to bolster the launch of bloodless, cloud-based, clinical diagnostics at Inmedix, Inc. | |
| Myriad partners with OptraHealth for AI ... | 07/06/20 |
| Myriad Genetics (NASDAQ:MYGN) partners with OptraHEALTH to implement a cognitive ChatBOT named Gene to provide genetic and financial assistance inform... | |
| Myriad Genetics' Test Better Predicts Dr... | 06/09/20 |
| Myriad Genetics' (MYGN) GeneSight Psychotropic test is shown to be superior at predicting blood concentrations unlike single-gene testing as demonstra... | |
| Why Is Myriad (MYGN) Up 8.9% Since Last ... | 06/04/20 |
| Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Myriad Genetics Announces Publication of... | 06/04/20 |
| EndoPredict Predicts Response to Neoadjuvant Chemotherapy and Endocrine Therapy | |
| Zacks.com featured highlights include: M... | 05/27/20 |
| Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories | |
| Myriad's (MYGN) EndoPredict Grows Amid C... | 05/18/20 |
| Within Molecular Diagnostics, Myriad Genetics (MYGN) registers strong sales for EndoPredict, myChoice CDx and BRACAnalysis CDx. | |
| Myriad Genetics (MYGN) Lags Q3 Earnings ... | 05/06/20 |
| Myriad Genetics (MYGN) reports revenue declines in both reporting segments in Q3 resulting from coronavirus-led business disruptions. | |
| Shared-Use Space For Cannabis Manufactur... | 04/07/20 |
| My Green Network (MyGN) is set to open a membership-based, entrepreneur-focused, collaborative cannabis facility inin Orange County, California this s... | |
| Myriad Genetics' (MYGN) BRACAnalysis Get... | 04/07/20 |
| Myriad Genetics (MYGN) launches BRACAnalysis Diagnostic System in Japan, after receiving reimbursement for the system, which will enable easier identi... | |
| Myriad Grows Internationally, Hereditary... | 03/19/20 |
| Myriad Genetics (MYGN) registers soft Hereditary Cancer, GeneSight, Vectra as well as Prenatal revenues in second-quarter fiscal 2020. | |
| Myriad Genetics : A letter from Bryan Ri... | 03/16/20 |
| March 16, 2020 Dear Customer, At Myriad, we are actively monitoring the COVID-19/Coronavirus situation and have implemented a business??? | March 17, ... | |
| The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... | |
| Myriad (MYGN) Down 44.1% Since Last Earn... | 03/07/20 |
| Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Zacks.com featured highlights include: E... | 03/04/20 |
| Zacks.com featured highlights include: Envestnet, First Majestic Silver, Myriad Genetics, Vericel and Casella Waste Systems | |
| The Zacks Analyst Blog Highlights: Abbot... | 02/28/20 |
| The Zacks Analyst Blog Highlights: Abbott Laboratories, Myriad Genetics, LabCorp, QIAGEN and Thermo Fisher | |
| The Daily Biotech Pulse: Gilead Kicks Of... | 02/27/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Moderna Ships C... | 02/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) ... | |
| Myriad Genetics (MYGN) Releases Favorabl... | 02/17/20 |
| This study result is a major breakthrough and is expected to strengthen Myriad Genetics' (MYGN) Oncology segment. | |
| Myriad Genetics (MYGN) Files for myChoic... | 02/13/20 |
| With the receipt of the regulatory approval, Myriad Genetics (MYGN) will be taking a major stride forward in its Oncology and Women's Health segment. | |
| The Law Offices of Frank R. Cruz Announc... | 02/07/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $MYGN #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors... | |
| Date | 2020-08-13 (AMC) | Est. (EPS/Rev.) | ($0.47)/ 93.85M |
| Actual (EPS/Rev.) | $-0.31/ $93.20 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
